L. E. Bermudez, Kolonoski, P., Petrofsky, M., Wu, M., Inderlied, C. B., and Young, L. S.,
“Mefloquine, moxifloxacin, and ethambutol are a triple-drug alternative to macrolide-containing regimens for treatment of Mycobacterium avium disease.”,
The Journal of infectious diseases, vol. 187, no. 12, pp. 1977-80, 2003.
K. M. Sandoz, Eriksen, S. G., Jeffrey, B. M., Suchland, R. J., Putman, T. E., Hruby, D. E., Jordan, R., and Rockey, D. D.,
“Resistance to a novel antichlamydial compound is mediated through mutations in Chlamydia trachomatis secY.”,
Antimicrob Agents Chemother, vol. 56, no. 8, pp. 4296-302, 2012.
G. Carter, Young, L. S., and Bermudez, L. E.,
“A subinhibitory concentration of clarithromycin inhibits Mycobacterium avium biofilm formation.”,
Antimicrobial agents and chemotherapy, vol. 48, no. 12, pp. 4907-10, 2004.